ACHE and myasthenia gravis: Moxifloxacin, a fourth generation synthetic fluoroquinolone, has been contra-indicated in patients suffering from myasthenia gravis, which is in accordance with the apparent ability of Euphorbia hirta to restore acetylcholinesterase activity (23,27).